These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 572776)

  • 1. Central noradrenergic--cholinergic interaction and locomotor behavior.
    Mason ST
    Eur J Pharmacol; 1979 Jun; 56(1-2):131-7. PubMed ID: 572776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic influences on catalepsy.
    Mason ST; Roberts DC; Fibiger HC
    Psychopharmacology (Berl); 1978 Dec; 60(1):53-7. PubMed ID: 104346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy.
    Roberts DC; Mason ST; Fibiger HC
    Eur J Pharmacol; 1978 Nov; 52(2):209-14. PubMed ID: 569587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
    Ahtee L
    Eur J Pharmacol; 1976 Oct; 39(2):203-13. PubMed ID: 987911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilocarpine: noradrenergic mechanism of a cholinergic drug.
    Mason ST
    Neuropharmacology; 1978 Dec; 17(12):1015-21. PubMed ID: 570647
    [No Abstract]   [Full Text] [Related]  

  • 6. Noradrenergic processes involved in the locomotor effects of ethanol.
    Mason ST; Corcoran ME; Fibiger HC
    Eur J Pharmacol; 1979 Mar; 54(4):383-7. PubMed ID: 436937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between noradrenergic and cholinergic systems in the rat brain: behavioural function in locomotor activity.
    Mason ST; Fibiger HC
    Neuroscience; 1979; 4(4):517-25. PubMed ID: 431828
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists.
    McGurk SR; Levin ED; Butcher LL
    Neuroscience; 1991; 44(1):137-47. PubMed ID: 1770993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotine on single cell activity in the noradrenergic nucleus locus coeruleus.
    Svensson TH; Engberg G
    Acta Physiol Scand Suppl; 1980; 479():31-4. PubMed ID: 6932803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholinergic agents on locomotor activity of P and NP rats.
    Katner SN; McBride WJ; Lumeng L; Li TK; Murphy JM
    Alcohol Clin Exp Res; 1996 Sep; 20(6):1004-10. PubMed ID: 8892519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological analysis of a cholinergic receptor mediated regulation of brain norepinephrine neurons.
    Engberg G; Svensson TH
    J Neural Transm; 1980; 49(3):137-50. PubMed ID: 7452224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic drugs regulate passive avoidance performance via the amygdala.
    Riekkinen P; Riekkinen M; Sirviö J
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible behavioural function for noradrenaline--acetylcholine interaction in brain.
    Mason ST; Fibiger HC
    Nature; 1979 Feb; 277(5695):396-6. PubMed ID: 575915
    [No Abstract]   [Full Text] [Related]  

  • 14. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior.
    Mohammed AK; Danysz W; Ogren SO; Archer T
    Neurosci Lett; 1986 Feb; 64(2):139-44. PubMed ID: 3008041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine.
    Retz KC; Trimmer CK; Forster MJ; Lal H
    Pharmacol Biochem Behav; 1987 Oct; 28(2):275-82. PubMed ID: 3685061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral cholinergic involvement in the habituation of investigatory head poking in rats.
    Green SE; Summerfield A
    J Comp Physiol Psychol; 1977 Dec; 91(6):1398-1407. PubMed ID: 599198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical basis of the dorsal bundle extinction effect.
    Mason ST; Fibiger HC
    Pharmacol Biochem Behav; 1979 Mar; 10(3):373-80. PubMed ID: 450950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats.
    Kim JS; Levin ED
    Brain Res; 1996 Jul; 725(2):231-40. PubMed ID: 8836529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
    Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
    J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.